NP+PA Perspectives in Dermatology | JCAD | The Journal of Clinical and Aesthetic Dermatology

Full Digital Editions:

NP+PA Perspectives in Dermatology: July–August 2024

NP+PA Perspectives in Dermatology: May–June 2024

Dermatology Conference Highlights 2024: Atopic Dermatitis

Current Issue: Featured Articles

Dermatology NP & PA Workforce Survey—Practice Characteristics and Compensation

J Clin Aesthet Dermatol. 2023;16(2 Suppl 1):S16–24. by Margaret A. Bobonich, DNP, FNP-C, DCNP, FAANP; Veronica Richardson, MSN, ANP-C, DCNP; and Sotero Alvarado, MA Dr. Bobonich is Assistant Professor...

Editorial Message: Matthew T. Reynolds, MS, MPAS, PA-C

J Clin Aesthetic Dermatol 2022;15(12 Suppl 1):S8 Dear Colleagues: This year, we have seen many advances in the field of dermatology. In the realm of therapeutics, we have seen fundamental game-changing...

Spotlight Interview: Matthew T. Reynolds, MS, MPAS, PA-C

J Clin Aesthetic Dermatol 2022;15(12 Suppl 1):S13–S15 Matthew T. Reynolds, MS, MPAS, PA-C, a native of Arkansas, received his physician assistant training at the University of Arkansas for Medical Sciences...

Dermatological Conditions in Skin of Color— Debunking Vitiligo Myths

J Clin Aesthet Dermatol. 2022;15(9 Suppl 1):S10–11 by Archana M. Sangha, MMS, PA-C Ms. Sangha is a medical science liaison for Incyte in Wilmington, Delaware. Prior to that, she spent over a decade as...

Editorial Message from Guest Editor Susan Mayne, DNP, FNP-C, DCNP

Dear Colleagues: The pharmaceutical floodgates have recently burst, and many of us struggle to keep up with the safety and efficacy of new medications along with emerging safety risks of familiar medications....

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next

Trending on JCAD TV

Shanna Miranti, MPAS, PA-C: Assessing Treatment Efficacy in Patients with Vitiligo

How to Get Published in JCAD NP+PA Perspectives in Dermatology

Atopic Dermatitis Advisor Audio Series:

Incorporating Topical and Oral Treatments into Practice

Nicole Keeter, MSHS, PA-C, describes how to implement various JAK inhibitors into practice for the treatment of atopic dermatitis, psoriasis, and alopecia areata. She discusses how utilizing these JAK inhibitors in the treatment of atopic dermatitis has shown to provide a rapid decrease in symptoms, particularly pruritus.

JCAD | The Journal of Clinical and Aesthetic Dermatology